Practice Point®: Hematology

Practice Point Communications

Tune in to our hematology podcasts, where experts in the field of blood diseases unravel the complexities of hematology. Each episode covers the latest breakthroughs in the diagnosis, treatment, and management of hematologic conditions like leukemia, hemophilia, multiple myeloma and more. With in-depth discussions from leading hematologists, and insights from real-world cases, this podcast series provides healthcare professionals with the knowledge needed to navigate the world of blood disorders. Stay informed about cutting-edge research and hear inspiring stories of innovation in hematologic care.

  1. Episode 46 - What's New Doc? End-of-the-Year Updates on CAR T-cell Therapy in Multiple Myeloma Podcast

    12/17/2025

    Episode 46 - What's New Doc? End-of-the-Year Updates on CAR T-cell Therapy in Multiple Myeloma Podcast

    CAR T-cell therapies have transformed the management of several previously incurable, treatment-refractory hematologic malignancies, including Multiple Myeloma (MM). With two CAR T-cell products now approved, and additional under investigation, the therapeutic landscape continues to evolve rapidly. In this educational podcast, Dr. Joseph Mikhael highlights key advances in CAR T-cell therapy for MM. He reviews the most impactful data published or presented in 2025 and offers expert insight into how these emerging findings may shape current and future treatment strategies. Launch/Release Date: December 17, 2025 Activity Expiration Date: November 30, 2026 FACULTY Joseph Mikhael, MD, MEd, FRCPC, FACP, FASCO Professor, Clinical Genomics and Therapeutics Translational Genomics Research Institute (TGen), City of Hope Cancer Center Chief Medical Officer International Myeloma Foundation This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

    30 min
  2. Episode 45 - Clinical Clips® Crucial Advances in Hemophilia

    12/12/2025

    Episode 45 - Clinical Clips® Crucial Advances in Hemophilia

    A number of clinical trials are underway to reduce and prevent bleeding episodes among patients with hemophilia and to improve their overall quality of life by improving joint health and addressing patient needs/concerns. These include both replacement and novel non-replacement therapies. This activity is designed to update healthcare professionals with the latest cutting-edge evidence in hemophilia treatment that was presented during the annual hematology meeting in Orlando, FL. The Clinical Clips format will equip clinicians with the knowledge and confidence to integrate new evidence into personalized approaches, optimize patient outcomes, and improve the overall quality of care in hemophilia A and B. Launch/Release Date: December 12, 2025 Activity Expiration Date: November 30, 2026 FACULTY Angela Weyand, MD Associate Professor, Pediatrics University of Michigan Medical School Pediatric Medical Director University of Michigan HTC Co-Director, Hematology and Pediatric and Adolescent Gynecology Program Ann Arbor, Michigan This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

    19 min
  3. Episode 44 - Hematologic Cancer Updates | Key Advances in Leukemia, MDS and MF Podcast

    12/10/2025

    Episode 44 - Hematologic Cancer Updates | Key Advances in Leukemia, MDS and MF Podcast

    Breakthroughs in hematologic cancers continue to emerge. Staying aligned with the newest insights from leading medical conferences is essential for healthcare providers committed to delivering cutting-edge care. Through impactful presentations, posters and abstracts, Dr. Raajit Rampal provides expert commentary on the latest advances in Leukemia, Myelodysplastic Syndromes (MDS) and Myelofibrosis (MF) presented at the annual hematology meeting in Orlando, FL. Launch/Release Date: December 10, 2025 Activity Expiration Date: November 30, 2026 FACULTY Raajit Rampal, MD, PhD Director, Myeloproliferative Neoplasms Program Director, Center for Hematologic Malignancies Memorial Sloan Kettering Cancer Center This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

    21 min
  4. Episode 43 - Integrating Emerging Therapies into Clinical Practice for Pediatric ITP: Exploring Evidence, Guidelines and Best Practices

    07/07/2025

    Episode 43 - Integrating Emerging Therapies into Clinical Practice for Pediatric ITP: Exploring Evidence, Guidelines and Best Practices

    In this podcast, Dr. Cindy Neunert, provides expert insights into emerging data on ITP pathophysiology, diagnosis, and treatment, equipping healthcare providers with the knowledge to translate new research into clinical practice and improve pediatric patient care. Launch Date: July 7, 2025 Release Date: July 7, 2025 Expiration Date: June 30, 2026 FACULTY Cindy Neunert, MD Division of Pediatric Hematology Oncology, and Stem Cell Transplantation Columbia University Irving Medical Center New York, New York This podcast provides accredited continuing education credits. To receive your credit, please read the accreditation information provided in this link prior to listening to this podcast.

    52 min
  5. Episode 42 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 4: Patient Perspective in Hemophilia Care

    02/04/2025

    Episode 42 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 4: Patient Perspective in Hemophilia Care

    There has been unprecedented research progress in the treatment of hemophilia heralded by the development of non-replacement therapies, emerging factor mimetics, and novel gene therapy agents. In this podcast series, Dr. Jonathan C. Roberts and Dr. Mindy Simpson inform and guide on safely integrating recently approved agents into the treatment continuum while ensuring alignment with critical new breakthroughs and enabling patient-focused care pathways. Launch Date: February 4, 2025 Release Date: February 4, 2025 Expiration Date: January 31, 2026 FACULTY Jonathan C. Roberts, MD Associate Medical Director Associate Research Director Bleeding and Clotting Disorders Institute Associate Professor of Pediatrics and Medicine University of Illinois College of Medicine at Peoria Mindy Simpson, MD Medical Director Rush Hemophilia and Thrombophilia Center Assistant Professor of Pediatrics in Pediatric Hematology/Oncology Rush University Medical Center This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information here prior to listening to this episode.

    21 min
  6. Episode 41 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 3: Relevance and Impact of Novel Agents in Hemophilia Care Paradigms

    02/04/2025

    Episode 41 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 3: Relevance and Impact of Novel Agents in Hemophilia Care Paradigms

    There has been unprecedented research progress in the treatment of hemophilia heralded by the development of non-replacement therapies, emerging factor mimetics, and novel gene therapy agents. In this podcast series, Dr. Jonathan C. Roberts and Dr. Mindy Simpson inform and guide on safely integrating recently approved agents into the treatment continuum while ensuring alignment with critical new breakthroughs and enabling patient-focused care pathways. Launch Date: February 4, 2025 Release Date: February 4, 2025 Expiration Date: January 31, 2026 FACULTY Jonathan C. Roberts, MD Associate Medical Director Associate Research Director Bleeding and Clotting Disorders Institute Associate Professor of Pediatrics and Medicine University of Illinois College of Medicine at Peoria Mindy Simpson, MD Medical Director Rush Hemophilia and Thrombophilia Center Assistant Professor of Pediatrics in Pediatric Hematology/Oncology Rush University Medical Center This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information here prior to listening to this episode.

    6 min
  7. Episode 40 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 2: Clinical Evidence on Novel Therapy Options in Hemophilia

    02/04/2025

    Episode 40 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 2: Clinical Evidence on Novel Therapy Options in Hemophilia

    There has been unprecedented research progress in the treatment of hemophilia heralded by the development of non-replacement therapies, emerging factor mimetics, and novel gene therapy agents. In this podcast series, Dr. Jonathan C. Roberts and Dr. Mindy Simpson inform and guide on safely integrating recently approved agents into the treatment continuum while ensuring alignment with critical new breakthroughs and enabling patient-focused care pathways. Launch Date: February 4, 2025 Release Date: February 4, 2025 Expiration Date: January 31, 2026 FACULTY Jonathan C. Roberts, MD Associate Medical Director Associate Research Director Bleeding and Clotting Disorders Institute Associate Professor of Pediatrics and Medicine University of Illinois College of Medicine at Peoria Mindy Simpson, MD Medical Director Rush Hemophilia and Thrombophilia Center Assistant Professor of Pediatrics in Pediatric Hematology/Oncology Rush University Medical Center This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information here prior to listening to this episode.

    21 min
  8. Episode 39 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 1: Rationale and Potential of Gene Therapy and Rebalancing Agents in Hemophilia

    02/04/2025

    Episode 39 - Talking Hemophilia: Evolving Frontiers in Hemophilia Treatment: Patient-Focused Strategies to Improve Outcomes - Part 1: Rationale and Potential of Gene Therapy and Rebalancing Agents in Hemophilia

    There has been unprecedented research progress in the treatment of hemophilia heralded by the development of non-replacement therapies, emerging factor mimetics, and novel gene therapy agents. In this podcast series, Dr. Jonathan C. Roberts and Dr. Mindy Simpson inform and guide on safely integrating recently approved agents into the treatment continuum while ensuring alignment with critical new breakthroughs and enabling patient-focused care pathways. Launch Date: February 4, 2025 Release Date: February 4, 2025 Expiration Date: January 31, 2026 FACULTY Jonathan C. Roberts, MD Associate Medical Director Associate Research Director Bleeding and Clotting Disorders Institute Associate Professor of Pediatrics and Medicine University of Illinois College of Medicine at Peoria Mindy Simpson, MD Medical Director Rush Hemophilia and Thrombophilia Center Assistant Professor of Pediatrics in Pediatric Hematology/Oncology Rush University Medical Center This podcast provides accredited continuing education credits. To qualify for credit, please read all accreditation information here prior to listening to this episode.

    22 min
See All (46)

About

Tune in to our hematology podcasts, where experts in the field of blood diseases unravel the complexities of hematology. Each episode covers the latest breakthroughs in the diagnosis, treatment, and management of hematologic conditions like leukemia, hemophilia, multiple myeloma and more. With in-depth discussions from leading hematologists, and insights from real-world cases, this podcast series provides healthcare professionals with the knowledge needed to navigate the world of blood disorders. Stay informed about cutting-edge research and hear inspiring stories of innovation in hematologic care.

Information

  • Creator
    Practice Point Communications
  • Years Active
    2K
  • Episodes
    46
  • Rating
    Clean
  • Copyright
    © Practice Point Communications 2025
  • Show Website
    Practice Point®: Hematology